Advertisement
Australia markets close in 5 hours 57 minutes
  • ALL ORDS

    7,932.00
    +25.40 (+0.32%)
     
  • ASX 200

    7,664.10
    +26.70 (+0.35%)
     
  • AUD/USD

    0.6474
    -0.0005 (-0.08%)
     
  • OIL

    81.41
    -0.52 (-0.63%)
     
  • GOLD

    2,302.70
    -0.20 (-0.01%)
     
  • Bitcoin AUD

    93,763.44
    -4,686.34 (-4.76%)
     
  • CMC Crypto 200

    1,298.49
    -40.58 (-3.03%)
     
  • AUD/EUR

    0.6069
    +0.0003 (+0.05%)
     
  • AUD/NZD

    1.1006
    +0.0015 (+0.14%)
     
  • NZX 50

    11,899.47
    -58.03 (-0.49%)
     
  • NASDAQ

    17,440.69
    -342.02 (-1.92%)
     
  • FTSE

    8,144.13
    -2.90 (-0.04%)
     
  • Dow Jones

    37,815.92
    -570.17 (-1.49%)
     
  • DAX

    17,932.17
    -186.15 (-1.03%)
     
  • Hang Seng

    17,763.03
    +16.12 (+0.09%)
     
  • NIKKEI 225

    38,405.66
    0.00 (0.00%)
     

Monthly information on share capital and company voting rights

Cellectis Inc.
Cellectis Inc.

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, April 04, 2024 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

Date

Total number of shares
in the capital

Total number of voting rights

03/31/2024

71,953,535

77,889,229

For further information on Cellectis, please contact:

Media contact:

Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com

Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93, media@cellectis.com

Investor Relations contacts:

Arthur Stril, Chief Business Officer, +1 (347) 809 5980, investors@cellectis.com

Ashley R. Robinson, LifeSci Advisors, +1 617 430 7577


Attachment